The following is a searchable and filterable list of our news posts, press releases, white papers, articles, scientific posters, and much more.
If you can’t find something, please let us know and we’ll reach out to you as soon as we can.
Dataome-powered Precision Medicine
the bioRN Life Science Cluster magazine – The Heidelberg Ecosystem has it all (for MH’s contribution see page 8)Open resourceMolecular Health and Axxam enter into a strategic partnership to bolster the discovery of innovative targets in drug development
Read moreRewiring Drug Research and Development through Human Data-Driven Discovery (HD3)
Jackson, D.B. et al. Pharmaceutics. 2023; 15(6), 1673. doi: 10.3390/pharmaceutics15061673Open resourceWhole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms
Brock, S. et al. Front. Mol. Med. 2023; 2:1035290. https://doi.org/10.3389/fmmed.2022.1035290Open resourceDaten töten. Den Krebs.
An article by Friedrich von Bohlen in FOCUS Die Welt in 2023 (in German)Download articleMolecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions
Press release, 10 March 2022Read moreAdvancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports
Soldatos, T. G. et al. CPT Pharmacometrics Syst Pharmacol. 2022; 11(5):540-555. doi: 10.1002/psp4.12765Open resourceApplication of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors
Kim, S. et al. Clin Transl Sci. 2022; 15(6):1430-1438. doi: 10.1111/cts.13254Open resourceThe COVID-19 explorer – An integrated, whole patient knowledge model of COVID-19 disease
Brock, S. et al. Front. Mol. Med. 2022; 2:1035215. https://doi.org/10.3389/fmmed.2022.1035215Open resourceMolecular Health and Essen University Hospital launch collaborative project to improve care for COVID-19 patients
Press release, 9 August 2021Read moreWir bringen die biologische Grammatik in die Medizin
Plattform Life Sciences “Smarte Medizin” – Interview with Friedrich von Bohlen (in German)Open resourceTarget adverse event profiles for predictive safety in the postmarket setting
Peter Schotland, Rebecca Racz, David B. Jackson, Theodoros G. Soldatos, Robert Levin, David G. Strauss and Keith Burkhart. Clinical Pharmacology & Therapeutics. 2021; 109(5):1232. doi: 10.1002/cpt.2074Open resourceMolecular Health – intelligent solutions for smarter healthcare
NATURE BiopharmaDealmakersOpen resourceDatenprojekt zu Covid-Langzeitfolgen startet
Handelsblatt (in German)Open resourceWie der MH Corona Explorer die Versorgung COVID-19-Kranker verbessern soll
ÄrzteZeitung (in German)Open resourceA case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development
Kim, S. et al. Clin Transl Sci. 2022; 15(4):1003-1013. doi: 10.1111/cts.13219Open resource